cro.directory
← Compare landing

PSI vs ProSciento

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/appian/prosciento

CategoryPSIProSciento
Listed sitecrocro
SummaryPSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.Specialized CRO focused on metabolic diseases (obesity, diabetes, MASLD/MASH, cardiovascular, chronic kidney disease) with two decades of expertise, a nationwide registry of 180,000+ participants, and full-service clinical development capabilities from Phase 1 through Phase 3.
Services
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Clinical Trial Services
Modalities
  • Cell Therapy
  • Gene Therapy
  • Radiopharmaceutical
Data not yet provided.
Indications
  • Oncology
  • Gastroenterology
  • Neurology
  • Infectious Disease
  • Respiratory
  • Immunology
  • Cardiovascular
  • Nephrology
  • Metabolic
  • Metabolic
  • Cardiovascular
  • Nephrology
Locations
  • Osaka, Osaka, Osaka, Japan
  • Headquarters, Chula Vista, California, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.